BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: www.biocentury.com
Szerző
BioCentury
Kategória
A podcast weboldala
Legutóbbi epizód
2026. okt. 27.
Hol hallgathatod?
Podcastok az alkalmazásban Replaio Radio HamarosanA podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz
Telepítsd ingyen
Android közel 10 M letöltés · 4,8-as értékelés
iOS hamarosan
Epizódok
Ep. 101 - Of Biotech Bears, Pazdur & PDUFA 08.02.2022 28:41
Weathering the bear market. Oncology chief’s change in thinking on PD-1 therapies. Plus BioCentury’s 2021 innovative start-ups. This week’s podcast is sponsored by ICON . Reach us by sending a text
Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns 01.02.2022 26:46
This week’s podcast is sponsored by ICON . Reach us by sending a text
Ep. 99 - Introducing The BioCentury Show, Plus Califf, COVID and GSK 25.01.2022 26:13
BioCentury’s new in-depth conversational series launches with Scott Gottlieb as debut guest. This week’s podcast is sponsored by ICON . Reach us by sending a text
Ep. 98 - Bargain Hunting in a Rocky Market, plus Advantage, CMS 19.01.2022 23:38
Part two of BioCentury’s 2022 Financial Markets Preview, access to Alzheimer’s mAbs, and translational highlights from the Distillery. This week’s podcast is sponsored by ICON . Reach us by sending a text
Ep. 97 - Buysiders' Picks, plus JPM22 roundup 11.01.2022 27:38
Reach us by sending a text
Ep. 96 - Aduhelm, Pazdur, Pharma Digital & '21 Wrap 21.12.2021 23:19
Reach us by sending a text
Ep. 95 - ASH's New Targets, Avistone & Washington Update 14.12.2021 19:36
Reach us by sending a text
Ep. 94 - Woodcock's To-Do List, Maraganore's Takeaways & the Distillery 07.12.2021 22:45
Reach us by sending a text
Ep. 93 - Omicron's Open Questions, Plus the Business Case for Ultra-rare Diseases 30.11.2021 19:54
Reach us by sending a text
Ep. 92 - Biogen’s R&D decision, previewing TIGIT & China Summit highlights 22.11.2021 23:13
Reach us by sending a text
Ep. 91 - China Summit Highlights: Day 2 18.11.2021 38:30
Reach us by sending a text
Ep. 90 - China Summit Highlights: Day 1 17.11.2021 36:05
Reach us by sending a text
Ep. 89 - Califf's Passions, RWE in China & LSP Rising 16.11.2021 32:57
Reach us by sending a text
Ep. 88 - China Summit Preview: The Bridge to Innovation 10.11.2021 28:14
Reach us by sending a text
Ep. 87 - Digesting Drug Pricing, Plus Access in ALS 09.11.2021 32:41
Reach us by sending a text
Ep. 86 - Woodcock's Legacy, Plus Frazier, Bain & the Distillery 02.11.2021 26:56
Reach us by sending a text
Ep. 85 - What's Next for CRISPR & Gene Therapy, Plus China Summit Preview 26.10.2021 23:28
Reach us by sending a text
Ep. 84 - Why Gene Therapy's Bad Year Is a Speed Bump, Not a Dead End 22.10.2021 23:08
Reach us by sending a text
Ep. 83 - Assessing Biogen’s ALS Miss, Plus Califf on Deck 18.10.2021 23:08
Reach us by sending a text
Ep. 82 - 4Q Markets Preview, Plus the Future of NIH 12.10.2021 30:34
Reach us by sending a text
Ep. 81 - Merck & the State of M&A, Plus Novartis CEO's Call to Action 05.10.2021 22:25
Reach us by sending a text
Ep. 80 - Hong Kong Rising, Plus Varmus' POV & Biden's FDA Choice 28.09.2021 27:25
Reach us by sending a text
Ep. 79 - ESMO, Jeito & the Latest from Washington 21.09.2021 23:21
Reach us by sending a text
Ep. 78 - Remembering Fred Frank, Lisa Raines, Plus CRISPR, Washington Updates 14.09.2021 27:01
Reach us by sending a text
Ep. 77 - Back to School Spotlight & Pressures on FDA 04.09.2021 22:17
Reach us by sending a text
Hasonló podcastok
Hallgasd a(z) BioCentury This Week podcastot a Replaióban
Rádió és podcastok egy alkalmazásban - ingyen és regisztráció nélkül. Telepítsd még ma, és ne maradj le a premierről
A Replaio nem podcastkiadó; a műsorok nevei, borítóképei és hanganyagai a szerzőiket illetik, és nyilvános RSS-csatornákon keresztül terjednek.
